CDF Announces Retirement of Jim Watson from Board of Directors
Celiac Disease Foundation honors retiring Board Member Jim Watson for his dedicated service.
Continue ReadingCeliac Disease Foundation honors retiring Board Member Jim Watson for his dedicated service.
Continue ReadingCeliac Disease Foundation honors retiring Board Member Rhonda Resnick for her dedicated service.
Continue ReadingWith more than 200 symptoms, celiac disease can be difficult to diagnose. If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool made possible by the generous support of Proud Sponsor Schär.
Continue ReadingA new study has found that celiac disease (CeD) is linked to a higher risk of Juvenile Idiopathic Arthritis (JIA) among children with CeD and Rheumatoid Arthritis (RA) in adults with CeD.
Continue ReadingAs Thanksgiving approaches, we at the Celiac Disease Foundation are grateful for you, our celiac community, and the progress we are making – together – to accelerate diagnosis, treatment, and a cure for celiac disease.
Continue ReadingMedical Advisory Board Member Alessio Fasano, MD, and CDF Research Grant Award Recipient Marisa Stahl, MD, are among the leading celiac disease doctors and researchers who are recommending that celiac disease patients be tested for other autoimmune disorders.
Continue ReadingIt’s getting cold outside, so we’re heating up our ovens to make delicious gluten-free recipes! For a warm and filling snack or appetizer, check out Proud Sponsor Jones Dairy Farm’s Bacon Pimento Cheese Dip.
Continue ReadingFall is here – and so is the cooler weather – so here’s a perfect warm recipe for you! Try CDF Proud Sponsor BFree’s Roasted Tomato, Garlic, and Basil Soup with Cheesy Pesto Dippers.
Continue ReadingEvery November, the Celiac Disease Foundation hosts our annual, beloved Turkey Trot 5K, an inspirational event that raises funds for celiac disease research to accelerate treatments and a cure.
Continue ReadingThe Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.
Continue Reading